ReviewLife (Basel, Switzerland)2021
Definition of Sarcopenia in Chronic Liver Disease.
Review in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: a systematic review and meta-analysis.Revista da Associacao Medica Brasileira (1992) · 2025Pooled it
- Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review.Nutrients · 2024Pooled it
- Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis.Frontiers in nutrition · 2022Pooled it
- Construction of a nomogram prediction model for opportunistic sarcopenia in patients with malignant tumors.Asia Pacific journal of clinical nutrition · 2026Article
- Lower-limb muscle mass quantification and whole-body muscle loss detection using preoperative computed tomography images in patients with hip disease.International journal of computer assisted radiology and surgery · 2025Article
- Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study.BMC gastroenterology · 2025Observational
- Impact of sociodemographic disparities on sarcopenia, telomere length, and mortality in patients with liver disease in the US population.BMC gastroenterology · 2024Article
- Low muscle quality index is associated with increased risk of advanced fibrosis in adult patients with nonalcoholic fatty liver disease: NHANES 2011-2014.Scientific reports · 2024Article
- Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.BMC gastroenterology · 2024Article
- Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China.Hepatology international · 2024Article
- Advanced liver fibrosis is associated with decreased gait speed in older patients with chronic liver disease.Scientific reports · 2024Article
- Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease.Gastro hep advances · 2024Article
- Adipopenia in body composition analysis: a promising imaging biomarker and potential predictive factor for patients undergoing transjugular intrahepatic portosystemic shunt placement.The British journal of radiology · 2023Article
- Article
- Diet-Regulating Microbiota and Host Immune System in Liver Disease.International journal of molecular sciences · 2021Review
- Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis.Frontiers in nutrition · 2021Article
- Nutritional Management of a Liver Transplant Candidate.Journal of clinical and experimental hepatologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia, which is characterized by decline in muscle mass, muscle strength, and physical performance, is common in patients with chronic liver disease (CLD) and is associated with poor clinical outcomes. Several consensus definitions for community-dwelling elderly people have been proposed, and these recommend the use of various tools and tests to assess muscle properties and performance. These measurement tools have also been applied in patients with CLD and have been useful for predicting prognosis. However, sarcopenia and its diagnostic criteria specific to patients with CLD have not yet been clearly defined. In addition, fluid retention and body composition should be considered when sarcopenia is assessed in patients with CLD. This review aims to introduce definitions of sarcopenia and diagnostic tools used in patients with CLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.